High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin - PubMed (original) (raw)

High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin

L Shahrabani-Gargir et al. Genet Test. 1998.

Abstract

Bloom syndrome (BS) is an autosomal recessive disorder characterized by small stature, immunodeficiency, chromosomal instability, and a predisposition to different types of cancer. Although extremely rare in the general population, BS is seen in about 1 in 48,000 Ashkenazi Jews. Mutation analysis of seven Ashkenazi BS probands has shown that all were homozygous for the same mutation in the BLM gene: 2281delATCTGAinsTAGATTC, also known as blmAsh. This finding, along with the increased incidence of BS among Ashkenazi Jews, suggests a founder effect for BS in this population. The purpose of this study was to determine the frequency of blmAsh mutation carriers in a randomly sampled Ashkenazi Jewish population in Israel. The initial study group included 1,613 Ashkenazi Jews who were referred for routine DNA screening tests (cystic fibrosis, Gaucher, Canavan, fragile X). None had a family history of BS. A group of 552 non-Ashkenazi Jews served as controls. Mutation analysis was performed by PCR amplification followed by analysis of a specific BstN1 restriction site, created by the blmAsh mutation. All positive carriers were confirmed by direct sequencing. Sixteen blmAsh carriers were detected among 1,613 Ashkenazi Jews (1 in 101), compared to none among 552 non-Ashkenazi individuals. In this study, Ashkenazi Jews of biparental Polish descent had a significantly higher proportion of the blmAsh mutation (1 in 37) compared to Ashkenazi Jews of non-Polish descent. These results provide further evidence that a founder effect is responsible for the increased incidence of Bloom syndrome among Ashkenazi Jews, particularly those of Polish descent.

PubMed Disclaimer

Similar articles

• Carrier frequency of the Bloom syndrome blmAsh mutation in the Ashkenazi Jewish population.
  Li L, Eng C, Desnick RJ, German J, Ellis NA. Li L, et al. Mol Genet Metab. 1998 Aug;64(4):286-90. doi: 10.1006/mgme.1998.2733. Mol Genet Metab. 1998. PMID: 9758720
• Ashkenazi Jewish population frequency of the Bloom syndrome gene 2281 delta 6ins7 mutation.
  Roa BB, Savino CV, Richards CS. Roa BB, et al. Genet Test. 1999;3(2):219-21. doi: 10.1089/gte.1999.3.219. Genet Test. 1999. PMID: 10464671
• A rapid method for detecting the predominant Ashkenazi Jewish mutation in the Bloom's syndrome gene.
  Straughen JE, Johnson J, McLaren D, Proytcheva M, Ellis N, German J, Groden J. Straughen JE, et al. Hum Mutat. 1998;11(2):175-8. doi: 10.1002/(SICI)1098-1004(1998)11:2<175::AID-HUMU11>3.0.CO;2-W. Hum Mutat. 1998. PMID: 9482582
• [Bloom syndrome].
  Kondo N. Kondo N. Nihon Rinsho. 2000 Jul;58(7):1460-6. Nihon Rinsho. 2000. PMID: 10921324 Review. Japanese.
• Cystic fibrosis in Jews: frequency and mutation distribution.
  Kerem B, Chiba-Falek O, Kerem E. Kerem B, et al. Genet Test. 1997;1(1):35-9. doi: 10.1089/gte.1997.1.35. Genet Test. 1997. PMID: 10464623 Review.

Cited by

• Bloom syndrome with myelodysplastic syndrome that was converted into acute myeloid leukaemia, with new ophthalmologic manifestations: the first report from Syria.
  Aljarad S, Alhamid A, Rahmeh AR, Alibraheem A, Wafa A, Alachkar W, Aljarad Z, Aziz G. Aljarad S, et al. Oxf Med Case Reports. 2018 Nov 5;2018(12):omy096. doi: 10.1093/omcr/omy096. eCollection 2018 Dec. Oxf Med Case Reports. 2018. PMID: 30410776 Free PMC article.
• A unique case of Bloom syndrome with a combination of genetic hits: A lesson from trio‑based exome sequencing: A case report.
  Wayhelova M, Vallova V, Broz P, Mikulasova A, Machackova D, Filkova HD, Smetana J, Takacsova A, Gaillyova R, Kuglik P. Wayhelova M, et al. Mol Med Rep. 2023 May;27(5):110. doi: 10.3892/mmr.2023.12997. Epub 2023 Apr 13. Mol Med Rep. 2023. PMID: 37052241 Free PMC article.
• A founder deletion in the TRPM1 gene associated with congenital stationary night blindness and myopia is highly prevalent in Ashkenazi Jews.
  Hirsch Y, Zeevi DA, Lam BL, Scher SY, Bringer R, Cherki B, Cohen CC, Muallem H, Chiang JP, Pantrangi M, Ekstein J, Johansson MM. Hirsch Y, et al. Hum Genome Var. 2019 Sep 12;6:45. doi: 10.1038/s41439-019-0076-4. eCollection 2019. Hum Genome Var. 2019. PMID: 31645983 Free PMC article.
• Time to bloom.
  Tikoo S, Sengupta S. Tikoo S, et al. Genome Integr. 2010 Nov 4;1(1):14. doi: 10.1186/2041-9414-1-14. Genome Integr. 2010. PMID: 21050475 Free PMC article.
• Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection.
  Risch N, Tang H, Katzenstein H, Ekstein J. Risch N, et al. Am J Hum Genet. 2003 Apr;72(4):812-22. doi: 10.1086/373882. Epub 2003 Feb 24. Am J Hum Genet. 2003. PMID: 12612865 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon